Pulse Biosciences, Inc Common Stock (DE)

PLSE · Medical Instruments · $3.8B
Powering up
PLSE
$53.87
▲ +6.44%
09/18 O 50.61 H 54.29 L 50.24 C 53.87 ▲ +6.44%
Vol 867.5K RS 98
RS rating98
Now vs pivot (%)+73.77%
Tightening (ATR ratio)1.32×
Volume dry-up1.66×
Up/down volume, net0.33
From 52-week high9%
squatclimbing
Previous breakout stopped out ▼ −9.41% in May
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

The read

The base has run 3.4 weeks and fell 20% from its ceiling at its deepest. The pivot is $31.00, and the stock closed 73.8% above that pivot. Its relative strength rating is 98.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap
  1. Earningstentativein 48d
    Quarterly earnings
    Nov 5, 2026
Flagged by the market sweep
GappedTape · 2026-09-17
-10.1%
Red flag in a filingFiling · 2026-09-16
material weakness

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.

In the news

No headlines for this company in the last couple of weeks.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Pulse Biosciences, Inc Common Stock (DE) (PLSE) — The Tape